• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1992 Fiscal Year Final Research Report Summary

Oxygen radical-induced tissue injury

Research Project

Project/Area Number 02557090
Research Category

Grant-in-Aid for Developmental Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Biological pharmacy
Research InstitutionUNIVERSITY OF TOKYO

Principal Investigator

KUDO Ichiro  Univ. Tokyo, Associate Professor, 薬学部, 助教授 (30134612)

Co-Investigator(Kenkyū-buntansha) TAKAMURA Tadanobu  Eisai, Tsukuba Research Institute, Senior Researcher, 研究開発部, 主任研究員
ARAI Hiroyuki  Univ. Tokyo, Instructor, 薬学部, 助手 (40167987)
UMEDA Masato  Univ. Tokyo, Instructor, 薬学部, 助手 (10185069)
Project Period (FY) 1990 – 1992
KeywordsIschemia / Phospholipase A2 / liver injury
Research Abstract

Phospholipid-hydrolyzing activities were examined in rat hearts with ischemia induced by occlusion of the left main coronary artery. When homogenates of ischemic heart were incubated in vitro at 37 ゚C, a significant amount of phosphatidylethanolamine (PE) was degraded, whereas the contents of other phospholipids did not change significantly. During the incubation, a stoichiometrical amount of lysoPE bearing mainly saturated fatty acids, whose composition resembled that of fatty acids detected at the sn-1 position in the glycerol backbone of heart PE, was formed concomitantly. No appreciable PE degradation was observed in homogenates prepared from nonischemic heart. No difference in phospholipase activities was found between ischemic and nonischemic heart homogenates when exogenous radioactive phospholipids were used as substrates. Anti-rat type II phospholipase A_2(PLA_2) antibody suppressed the degradation of PE observed in ischemic heart homogenates. These findings indicate that type II PLA_2 activity may be involved in the breakdown of endogenous PE in ischemic heart homogenates.
Activation of type II PLA_2, leading to hydrolysis of endogenous PE, was also observed in other oxygen radical-induced tissue injury, such as CCl_4-treated rat liver. Certain lipid-derived compound(s), which activated type II PLA_2, were detected in homogenate of CCl_4-treated liver. In the presence of lipids derived from CCl_4-treated liver, type II PLA_2 was significantly activated at lower (10^<-6> to 10^<-5> M) Ca^<2+> concentrations. Production of peroxidized lipids might explain the progressed breakdown of endogenous PE by type II PLA_2 in oxygen-injured tissues.

  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] Makoto MURAKAMI: "Release of 14-kDa group-2 phospholipase A_2 from activated mast cells and its possible involvement in the regulation of the degranulation process" Eur.J.Biochem. 209. 257-265 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Makoto MURAKAMI: "Molecular Nature of Phospholipases A_2 Involved in Prostaglandin I_2 Synthesis in Human Umbliical Vein Endothelial Cells" The Journal of Biological Chemistry. 268. 839-844 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 工藤 一郎: "高等動物非膵型ホスホリパーゼA_2:構造,性状,機能" 生化学. 64. 1330-1344 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Makoto Murakami, Ichiro Kudo, Yorimasa Suwa, and Keizo Inoue: "Release of 14-kDa group II phospholipase A2 from activated mast cells and its possible involvement in the regulation of the degranulation process" Eur. J. Biochem.209. 257-265 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mokoto Murakami, Ichiro Kudo, and Keizo Inoue: "Molecular nature of phospholipase A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells" J. Biol. Chem.268. 839-844 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ichiro Kudo and Keizo Inoue: "Review: Mammalian non-pancreatic phospholipase A2: Structure, properties, function" Biochemistry (in Japanese). 64. 1330-1344 (1992)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1994-03-24  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi